Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.15), $0.03 better than the analyst estimate of ($0.18). Revenue for the quarter came in at $5.2 million versus the consensus estimate of $6.17 million.

For earnings history and earnings-related data on Cytosorbents (CTSO) click here.